When pain has lingered long enough, injection options can begin to sound alike. Both prolotherapy and platelet-rich plasma, or PRP, are often described as regenerative approaches. Both may be discussed when a joint, tendon, or ligament has not settled with time and conservative care alone. But they are not the same treatment, and the difference is more than the name on the syringe.
At ReNova Health, we believe a useful comparison begins with mechanism, then moves to the practical questions that matter in real life: what is being injected, what does the evidence actually say, what is the appointment like, and what fits your diagnosis and goals. We provide prolotherapy for chronic pain in Ames, and we discuss PRP clearly when patients are weighing the two approaches.
Understanding What Each Injection Contains
Prolotherapy typically involves an injection of a dextrose-based solution into carefully selected areas, often where connective tissue attaches to bone or where joint-supporting structures may be contributing to pain. The intent is not simply to numb an area. It is to create a controlled local stimulus that may initiate a healing response.
The proposed biology is still being studied. Hypertonic dextrose may influence inflammatory signaling, cellular activity, and tissue remodeling, although the precise pathway likely varies by tissue and clinical presentation. A recent review describes the proposed mechanisms of dextrose prolotherapy and the need for continued, higher-quality research (Huang et al., 2025). We explore this distinction further in how prolotherapy works, because the idea of controlled irritation deserves more explanation than a quick slogan.
PRP begins with a blood draw. The blood is processed to concentrate platelets, then the resulting preparation is injected into a selected area. Platelets contain signaling molecules involved in normal tissue repair. Yet PRP is not one uniform substance. Platelet concentration, white blood cell content, activation methods, and preparation systems can differ meaningfully from one setting to another.
That variability is one reason broad claims about PRP can be misleading. An American Academy of Orthopaedic Surgeons review of PRP for knee osteoarthritis noted substantial variation across PRP studies and preparations (Dubin et al., 2024). The treatment material matters. So does the clinical question being asked.
The Difference Is Not Just Dextrose Versus Platelets
It is tempting to reduce this decision to a simple choice: prolotherapy uses a dextrose solution, while PRP uses a component of your own blood. That is true, but incomplete.
With prolotherapy, our clinical focus is on the structure under consideration, the pattern of pain, the quality of joint stability, and whether a tendon or ligament may be involved. We offer prolotherapy for chronic joint pain, tendon injuries, and ligament damage. A careful examination helps us determine whether that approach belongs in your care plan at all.
With PRP, the discussion includes the blood-processing step and the fact that protocols vary. PRP is often discussed in musculoskeletal care, but its appropriateness is not determined by a diagnosis alone. We do not treat a label on an imaging report. We evaluate the person carrying it.
There is also a practical difference. PRP appointments generally include a blood draw and processing time before injection. Prolotherapy does not require that preparation. Both approaches may involve targeted injection technique, and both can produce temporary post-injection soreness. The expected recovery window, activity modification, and follow-up plan should be discussed before you proceed, not after discomfort catches you by surprise.
What the Evidence Can, and Cannot, Tell You
Evidence can help frame a decision, but it rarely delivers a universal answer. Studies differ in patient selection, injection protocols, comparison treatments, outcome measures, and length of follow-up. A positive study does not mean the same result will occur for every patient.
For prolotherapy, a systematic review of osteoarthritis studies found improvements in pain and function reported across included trials, while also reflecting the limitations of a varied evidence base (Waluyo et al., 2023). That is encouraging context, not a promise. We discuss the quality of evidence alongside the details of your condition, including the role of imaging, movement, prior treatment, and daily function.
For PRP, the evidence is similarly specific to the problem being studied. A systematic review and meta-analysis of ultrasound-guided PRP for tendinopathies found research suggesting potential clinical benefit in selected tendinopathy studies (Masiello et al., 2023). It does not establish that PRP is the right choice for every tendon problem, or that one preparation is interchangeable with another.
Direct comparisons are also limited. A randomized trial comparing physiotherapy, shockwave therapy, prolotherapy, and PRP for chronic lateral epicondylosis illustrates how several nonoperative approaches may be studied side by side (Lhee et al., 2025). The meaningful takeaway is not that one injection wins in every setting. It is that diagnosis, protocol, time horizon, and individual response all matter.
The Questions We Consider Before Recommending Prolotherapy
An injection should follow a clinical question. Before discussing prolotherapy, we consider whether your pain appears to arise from a joint, tendon, ligament, nerve, muscle, or a combination of structures. Chronic pain can become layered. The place that hurts is not always the whole story.
We also ask about your history. Did symptoms begin after a distinct injury? Do you feel instability, catching, weakness, or pain with a specific motion? What treatments have you already tried, and what changed? These details help us decide whether prolotherapy is a reasonable option for chronic joint pain, tendon injuries, or ligament damage, or whether another direction makes more sense.
Your broader care may include activity modification, rehabilitation, and other conservative measures. Injection care is not always a substitute for strengthening or movement retraining. For some people, it is one part of a larger plan. Our regenerative pain management services are built around that fuller clinical picture.
Frequently Asked Questions
Is prolotherapy better than PRP?
Neither approach is automatically better. The relevant question is which, if either, fits the structure involved, your medical history, the available evidence, and your preferences. We discuss tradeoffs directly rather than presenting either option as a cure-all.
Does prolotherapy require a blood draw?
No. Prolotherapy generally uses a dextrose-based injectable solution. PRP requires a blood draw because the platelet-rich preparation is made from your own blood.
Will I need more than one injection?
Possibly. The answer depends on the diagnosis, your response, treatment goals, and the plan developed during your evaluation. Some patients may be candidates for a series, while others may not need or benefit from repeat treatment. We set expectations carefully and reassess rather than assuming a fixed number of visits is right for everyone.
Can an injection replace rehabilitation?
Not necessarily. Pain, tissue capacity, strength, movement patterns, and daily demands often overlap. Rehabilitation may remain an important part of care before or after an injection approach.
What should I bring to a consultation?
Bring prior imaging reports if you have them, a medication list, notes about previous procedures or therapies, and a clear account of what aggravates or relieves your symptoms. That history gives us more to work with than a diagnosis name alone.
Key Takeaways
- Prolotherapy and PRP use different treatment materials and involve different appointment processes.
- Prolotherapy uses a dextrose-based solution. PRP uses a platelet-rich preparation derived from your blood.
- Research for both approaches is evolving, and study results must be interpreted in context.
- We offer prolotherapy for chronic joint pain, tendon injuries, and ligament damage when an individualized evaluation supports that direction.
- The right next step is a conversation grounded in your symptoms, examination, goals, and prior care. If you would like to discuss whether prolotherapy may be appropriate, contact our Ames team.
Medical Disclaimer
This article is for educational purposes and is not medical advice. Injection-based care is not appropriate for every person or every source of pain. A clinical evaluation is needed to determine whether prolotherapy or another approach may be appropriate for you.
Works Cited
- Waluyo Y, et al. Efficacy of Prolotherapy for Osteoarthritis: A Systematic Review. https://pubmed.ncbi.nlm.nih.gov/36847731/
- Dubin J, et al. American Academy of Orthopaedic Surgeons Technology Overview Summary: Platelet-Rich Plasma (PRP) for Knee Osteoarthritis. https://pubmed.ncbi.nlm.nih.gov/38295392/
- Masiello F, et al. Ultrasound-guided injection of platelet-rich plasma for tendinopathies: a systematic review and meta-analysis. https://pubmed.ncbi.nlm.nih.gov/36346880/
- Lhee SH, et al. Comparing the Use of Physiotherapy, Shockwave Therapy, Prolotherapy, and Platelet-Rich Plasma for Chronic Lateral Epicondylosis: A Prospective, Randomized Controlled Trial With 2-Year Follow-up. https://pubmed.ncbi.nlm.nih.gov/40815854/
- Huang K, et al. Hypertonic dextrose prolotherapy in osteoarthritis: mechanisms, efficacy, and future research directions. https://pubmed.ncbi.nlm.nih.gov/40831953/
Disclaimer
This article is for educational purposes only and is not a substitute for individualized evaluation, diagnosis, or treatment from a qualified healthcare professional.